News Release 2009
-
- November 5, 2009
- Execution of License Agreement on Neramexane for Tinnitus with Merz Pharmaceuticals for Japan Territory
-
- September 29, 2009
- KYORIN and Eisai Sign License Agreement for Development and Marketing of Uritos® Tablets in China, India, Sri Lanka and ASEAN Countries
-
- August 5, 2009
- First Quarter Consolidated Financial Results for the Fiscal Year Ending March 31, 2010
-
- July 27, 2009
- Grant of Marketing Right to Senju Pharmaceutical on Gatifloxacin Ophthalmic Solution in China
-
- April 3, 2009
- Change of Representative Director and President at KYORIN Pharmaceutical
-
- April 3, 2009
- Change of Representative Director and President at KYORIN
-
- March 19, 2009
- KYORIN Announces Dissolution of Subsidiary
-
- March 19, 2009
- KYORIN Subsidiary (Investment LPS) to Be Dissolved
-
- February 27, 2009
- Execution of Licensing and Supply Agreement on Uritos® Tablets with SPIMACO
-
- February 5, 2009
- Third Quarter Consolidated Financial Results for the Fiscal Year Ending March 31, 2009
-
- February 4, 2009
- KYORIN Updates Credit Rating from R&I
-
- January 29, 2009
- Paper on Clinical Trial of MUCODYNE® for COPD Patients (PEACE Study) Chosen for THE LANCET Paper of the Year 2008
